| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Promotion | 6 | 2021 | 294 | 1.850 |
Why?
|
| Sunburn | 4 | 2020 | 7 | 1.740 |
Why?
|
| Skin Neoplasms | 5 | 2020 | 64 | 1.710 |
Why?
|
| Sunlight | 3 | 2020 | 16 | 1.580 |
Why?
|
| School Health Services | 3 | 2020 | 42 | 1.570 |
Why?
|
| Organizational Policy | 3 | 2020 | 17 | 1.480 |
Why?
|
| Colorectal Neoplasms | 11 | 2020 | 656 | 1.400 |
Why?
|
| Mass Screening | 9 | 2022 | 690 | 1.200 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2023 | 127 | 1.160 |
Why?
|
| Early Detection of Cancer | 9 | 2023 | 526 | 1.140 |
Why?
|
| Papillomavirus Infections | 3 | 2023 | 136 | 1.140 |
Why?
|
| Humans | 81 | 2023 | 18430 | 1.040 |
Why?
|
| Cost-Benefit Analysis | 13 | 2023 | 270 | 0.980 |
Why?
|
| Workplace | 4 | 2019 | 36 | 0.960 |
Why?
|
| Arthritis, Rheumatoid | 15 | 1997 | 40 | 0.940 |
Why?
|
| Female | 58 | 2023 | 13136 | 0.910 |
Why?
|
| Ultraviolet Rays | 2 | 2020 | 8 | 0.900 |
Why?
|
| Health Maintenance Organizations | 10 | 2007 | 479 | 0.810 |
Why?
|
| School Teachers | 2 | 2020 | 4 | 0.800 |
Why?
|
| Male | 54 | 2020 | 10440 | 0.790 |
Why?
|
| Middle Aged | 51 | 2023 | 8284 | 0.780 |
Why?
|
| Health Status | 10 | 2008 | 328 | 0.750 |
Why?
|
| Occupational Health | 2 | 2019 | 21 | 0.720 |
Why?
|
| Health Education | 2 | 2020 | 115 | 0.720 |
Why?
|
| Policy | 1 | 2020 | 19 | 0.710 |
Why?
|
| Schools | 5 | 2020 | 89 | 0.690 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 392 | 0.690 |
Why?
|
| Students | 1 | 2020 | 54 | 0.690 |
Why?
|
| Obesity | 5 | 2016 | 855 | 0.680 |
Why?
|
| Behavior Therapy | 1 | 2021 | 155 | 0.660 |
Why?
|
| Aged | 40 | 2023 | 6417 | 0.660 |
Why?
|
| Communication | 1 | 2020 | 202 | 0.630 |
Why?
|
| Weight Reduction Programs | 2 | 2016 | 60 | 0.620 |
Why?
|
| Surveys and Questionnaires | 19 | 2021 | 1389 | 0.610 |
Why?
|
| Parents | 1 | 2020 | 309 | 0.580 |
Why?
|
| Health Care Costs | 9 | 2008 | 251 | 0.560 |
Why?
|
| Antipsychotic Agents | 1 | 2016 | 57 | 0.520 |
Why?
|
| Adult | 37 | 2023 | 7910 | 0.520 |
Why?
|
| Reminder Systems | 5 | 2017 | 94 | 0.500 |
Why?
|
| Occult Blood | 7 | 2019 | 167 | 0.490 |
Why?
|
| United States | 19 | 2023 | 4164 | 0.460 |
Why?
|
| Costs and Cost Analysis | 7 | 2013 | 89 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 760 | 0.440 |
Why?
|
| Mental Disorders | 1 | 2016 | 295 | 0.430 |
Why?
|
| Primary Health Care | 3 | 2015 | 848 | 0.430 |
Why?
|
| Complementary Therapies | 2 | 2004 | 50 | 0.410 |
Why?
|
| Stroke | 2 | 2007 | 311 | 0.400 |
Why?
|
| Telephone | 4 | 2017 | 179 | 0.390 |
Why?
|
| Osteoarthritis | 5 | 1997 | 23 | 0.380 |
Why?
|
| Cystitis, Interstitial | 5 | 2008 | 6 | 0.360 |
Why?
|
| Risk Adjustment | 4 | 2003 | 32 | 0.360 |
Why?
|
| California | 4 | 2020 | 2365 | 0.350 |
Why?
|
| Data Collection | 4 | 2010 | 275 | 0.320 |
Why?
|
| Health Services Research | 4 | 2004 | 264 | 0.320 |
Why?
|
| Patient Compliance | 4 | 2017 | 318 | 0.320 |
Why?
|
| Weight Loss | 3 | 2014 | 321 | 0.320 |
Why?
|
| Internet | 2 | 2012 | 243 | 0.310 |
Why?
|
| Quality of Life | 5 | 2009 | 529 | 0.310 |
Why?
|
| Adolescent | 8 | 2020 | 3798 | 0.310 |
Why?
|
| Postal Service | 6 | 2023 | 83 | 0.310 |
Why?
|
| Coronary Thrombosis | 1 | 2007 | 1 | 0.290 |
Why?
|
| Child | 5 | 2020 | 2571 | 0.290 |
Why?
|
| Ischemic Attack, Transient | 1 | 2007 | 28 | 0.290 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2012 | 41 | 0.290 |
Why?
|
| Smoking Cessation | 3 | 2012 | 199 | 0.280 |
Why?
|
| Multicenter Studies as Topic | 2 | 2009 | 91 | 0.280 |
Why?
|
| Echocardiography | 2 | 2007 | 31 | 0.280 |
Why?
|
| Severity of Illness Index | 7 | 2009 | 476 | 0.280 |
Why?
|
| Oregon | 10 | 2019 | 222 | 0.270 |
Why?
|
| Medicaid | 1 | 2008 | 211 | 0.270 |
Why?
|
| Patient Selection | 3 | 2012 | 198 | 0.270 |
Why?
|
| Colonoscopy | 6 | 2019 | 268 | 0.270 |
Why?
|
| Papillomaviridae | 2 | 2023 | 53 | 0.270 |
Why?
|
| Delivery of Health Care, Integrated | 5 | 2012 | 567 | 0.260 |
Why?
|
| Managed Care Programs | 6 | 2008 | 347 | 0.250 |
Why?
|
| Health Status Indicators | 3 | 2008 | 71 | 0.250 |
Why?
|
| Aged, 80 and over | 13 | 2009 | 2003 | 0.250 |
Why?
|
| Technology Assessment, Biomedical | 2 | 2004 | 10 | 0.250 |
Why?
|
| Motivation | 3 | 2019 | 137 | 0.250 |
Why?
|
| Exercise | 3 | 2021 | 495 | 0.250 |
Why?
|
| Absenteeism | 3 | 2010 | 27 | 0.240 |
Why?
|
| Socioeconomic Factors | 5 | 2021 | 673 | 0.230 |
Why?
|
| Health Surveys | 2 | 2019 | 269 | 0.230 |
Why?
|
| Sunscreening Agents | 2 | 2020 | 7 | 0.220 |
Why?
|
| Research Design | 5 | 2014 | 402 | 0.220 |
Why?
|
| Alphapapillomavirus | 1 | 2022 | 14 | 0.210 |
Why?
|
| Prostatitis | 3 | 2007 | 8 | 0.210 |
Why?
|
| Endarterectomy, Carotid | 1 | 2002 | 7 | 0.210 |
Why?
|
| Carotid Stenosis | 1 | 2002 | 8 | 0.210 |
Why?
|
| Health Policy | 2 | 2020 | 136 | 0.200 |
Why?
|
| Medicare | 1 | 2023 | 214 | 0.200 |
Why?
|
| Drug Costs | 3 | 2003 | 40 | 0.190 |
Why?
|
| Accelerometry | 1 | 2021 | 37 | 0.190 |
Why?
|
| Chronic Disease | 6 | 2019 | 468 | 0.180 |
Why?
|
| Australia | 1 | 2020 | 23 | 0.180 |
Why?
|
| Treatment Outcome | 3 | 2021 | 1296 | 0.180 |
Why?
|
| Forecasting | 2 | 2003 | 80 | 0.180 |
Why?
|
| Disabled Persons | 2 | 1999 | 41 | 0.180 |
Why?
|
| Technology, High-Cost | 1 | 1999 | 1 | 0.170 |
Why?
|
| Medical Records Systems, Computerized | 2 | 2007 | 95 | 0.170 |
Why?
|
| Age Factors | 11 | 2015 | 965 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2010 | 342 | 0.170 |
Why?
|
| Community Health Centers | 1 | 2021 | 112 | 0.170 |
Why?
|
| Railroads | 1 | 2019 | 5 | 0.170 |
Why?
|
| Colorado | 1 | 2019 | 211 | 0.160 |
Why?
|
| Genetic Testing | 2 | 2012 | 89 | 0.160 |
Why?
|
| Program Evaluation | 1 | 2020 | 244 | 0.160 |
Why?
|
| Urinary Incontinence | 2 | 2009 | 33 | 0.160 |
Why?
|
| Health Services Needs and Demand | 1 | 1999 | 109 | 0.160 |
Why?
|
| Insurance Claim Review | 1 | 1998 | 70 | 0.160 |
Why?
|
| Hispanic Americans | 1 | 2021 | 428 | 0.160 |
Why?
|
| Environment Design | 1 | 2019 | 68 | 0.150 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 333 | 0.140 |
Why?
|
| Cost of Illness | 2 | 2010 | 100 | 0.140 |
Why?
|
| Urination Disorders | 2 | 2007 | 12 | 0.140 |
Why?
|
| Overweight | 2 | 2016 | 276 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2016 | 6 | 0.140 |
Why?
|
| Diet Therapy | 1 | 2016 | 12 | 0.140 |
Why?
|
| Time Factors | 4 | 2017 | 1136 | 0.130 |
Why?
|
| Risk Reduction Behavior | 1 | 2016 | 114 | 0.130 |
Why?
|
| Models, Economic | 1 | 1995 | 22 | 0.130 |
Why?
|
| Antirheumatic Agents | 1 | 1995 | 13 | 0.130 |
Why?
|
| Drug Monitoring | 1 | 1995 | 22 | 0.130 |
Why?
|
| Electronic Health Records | 3 | 2015 | 747 | 0.120 |
Why?
|
| Self Concept | 1 | 1995 | 42 | 0.120 |
Why?
|
| Patient Navigation | 1 | 2014 | 17 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2016 | 630 | 0.120 |
Why?
|
| Income | 3 | 1991 | 98 | 0.120 |
Why?
|
| Hospitalization | 2 | 2016 | 847 | 0.120 |
Why?
|
| Blood Glucose | 1 | 2016 | 346 | 0.120 |
Why?
|
| Economics, Medical | 2 | 2003 | 6 | 0.110 |
Why?
|
| Safety-net Providers | 1 | 2014 | 63 | 0.110 |
Why?
|
| Sex Factors | 7 | 2015 | 661 | 0.110 |
Why?
|
| Health Services Administration | 1 | 2013 | 6 | 0.110 |
Why?
|
| Secondary Prevention | 2 | 2007 | 52 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2012 | 7 | 0.110 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2012 | 16 | 0.110 |
Why?
|
| Patient-Centered Care | 1 | 2015 | 228 | 0.110 |
Why?
|
| ras Proteins | 1 | 2012 | 24 | 0.110 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 65 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 36 | 0.110 |
Why?
|
| Hawaii | 2 | 2010 | 45 | 0.110 |
Why?
|
| Decision Trees | 2 | 2007 | 20 | 0.100 |
Why?
|
| Mutation | 1 | 2012 | 132 | 0.100 |
Why?
|
| Knee Joint | 2 | 1989 | 4 | 0.100 |
Why?
|
| Specialization | 1 | 1991 | 26 | 0.100 |
Why?
|
| Manipulation, Chiropractic | 1 | 2011 | 22 | 0.100 |
Why?
|
| Internal Medicine | 1 | 1991 | 27 | 0.100 |
Why?
|
| Education, Medical, Graduate | 1 | 1991 | 20 | 0.100 |
Why?
|
| Acupuncture Therapy | 1 | 2011 | 36 | 0.100 |
Why?
|
| Case Management | 2 | 2003 | 37 | 0.100 |
Why?
|
| Body Mass Index | 3 | 2014 | 974 | 0.100 |
Why?
|
| Musculoskeletal Pain | 1 | 2011 | 28 | 0.100 |
Why?
|
| Reproducibility of Results | 4 | 2002 | 399 | 0.100 |
Why?
|
| Pilot Projects | 2 | 2008 | 237 | 0.090 |
Why?
|
| Risk Factors | 5 | 2014 | 3449 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2002 | 321 | 0.090 |
Why?
|
| Pelvic Pain | 2 | 2007 | 5 | 0.090 |
Why?
|
| Washington | 3 | 2019 | 388 | 0.090 |
Why?
|
| Regression Analysis | 5 | 2012 | 319 | 0.090 |
Why?
|
| Advertising as Topic | 2 | 2012 | 25 | 0.090 |
Why?
|
| Urodynamics | 1 | 2009 | 5 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2011 | 128 | 0.090 |
Why?
|
| Diagnostic Errors | 1 | 2009 | 29 | 0.090 |
Why?
|
| Self Care | 2 | 2022 | 175 | 0.080 |
Why?
|
| Models, Organizational | 2 | 2013 | 65 | 0.080 |
Why?
|
| Self Efficacy | 1 | 2009 | 71 | 0.080 |
Why?
|
| Child, Preschool | 3 | 2003 | 1478 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2003 | 872 | 0.080 |
Why?
|
| Hemochromatosis | 1 | 2008 | 9 | 0.080 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2008 | 8 | 0.080 |
Why?
|
| Ferritins | 1 | 2008 | 10 | 0.080 |
Why?
|
| Membrane Proteins | 1 | 2008 | 40 | 0.080 |
Why?
|
| Models, Statistical | 1 | 1989 | 185 | 0.080 |
Why?
|
| Decision Making | 2 | 2007 | 204 | 0.080 |
Why?
|
| Health | 2 | 1989 | 35 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2012 | 407 | 0.080 |
Why?
|
| Infant | 2 | 2003 | 1245 | 0.080 |
Why?
|
| Urologic Diseases | 1 | 2007 | 8 | 0.070 |
Why?
|
| Activities of Daily Living | 6 | 1999 | 96 | 0.070 |
Why?
|
| Monte Carlo Method | 1 | 2007 | 17 | 0.070 |
Why?
|
| Markov Chains | 1 | 2007 | 24 | 0.070 |
Why?
|
| Outcome Assessment (Health Care) | 2 | 1998 | 254 | 0.070 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 412 | 0.070 |
Why?
|
| Anticoagulants | 1 | 2007 | 125 | 0.070 |
Why?
|
| Smoking | 1 | 1989 | 494 | 0.070 |
Why?
|
| Follow-Up Studies | 3 | 2015 | 1269 | 0.070 |
Why?
|
| Continental Population Groups | 2 | 2012 | 315 | 0.060 |
Why?
|
| Educational Status | 2 | 2023 | 205 | 0.060 |
Why?
|
| Health Expenditures | 2 | 2003 | 82 | 0.060 |
Why?
|
| Family | 1 | 2005 | 120 | 0.060 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 35 | 0.060 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2023 | 5 | 0.060 |
Why?
|
| Prevalence | 4 | 2009 | 911 | 0.060 |
Why?
|
| Gold | 3 | 1995 | 3 | 0.060 |
Why?
|
| Young Adult | 3 | 2019 | 2518 | 0.060 |
Why?
|
| Outcome and Process Assessment (Health Care) | 1 | 2004 | 110 | 0.060 |
Why?
|
| Models, Theoretical | 1 | 2003 | 76 | 0.060 |
Why?
|
| Efficiency, Organizational | 2 | 2004 | 36 | 0.050 |
Why?
|
| Clinical Pharmacy Information Systems | 1 | 2003 | 11 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 188 | 0.050 |
Why?
|
| Cross-Sectional Studies | 3 | 2007 | 1360 | 0.050 |
Why?
|
| Ethnic Groups | 2 | 2007 | 501 | 0.050 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2002 | 9 | 0.050 |
Why?
|
| Carotid Arteries | 1 | 2002 | 10 | 0.050 |
Why?
|
| Health Care Coalitions | 1 | 2002 | 6 | 0.050 |
Why?
|
| Massachusetts | 3 | 1999 | 99 | 0.050 |
Why?
|
| Prospective Studies | 2 | 2019 | 1314 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2002 | 23 | 0.050 |
Why?
|
| Information Storage and Retrieval | 1 | 2002 | 16 | 0.050 |
Why?
|
| Community Health Planning | 1 | 2002 | 20 | 0.050 |
Why?
|
| Utilization Review | 1 | 2002 | 56 | 0.050 |
Why?
|
| Sigmoidoscopy | 2 | 2013 | 67 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2012 | 1143 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2019 | 1173 | 0.050 |
Why?
|
| Vital Signs | 1 | 2021 | 14 | 0.050 |
Why?
|
| Physicians | 1 | 2002 | 141 | 0.050 |
Why?
|
| Evidence-Based Medicine | 1 | 2002 | 195 | 0.050 |
Why?
|
| Attitude of Health Personnel | 1 | 2002 | 226 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2011 | 2550 | 0.050 |
Why?
|
| Sunbathing | 1 | 2020 | 1 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2012 | 133 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 126 | 0.040 |
Why?
|
| Midwestern United States | 1 | 1999 | 4 | 0.040 |
Why?
|
| Financial Support | 1 | 2019 | 6 | 0.040 |
Why?
|
| Northwestern United States | 1 | 1999 | 58 | 0.040 |
Why?
|
| ROC Curve | 1 | 1999 | 83 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 108 | 0.040 |
Why?
|
| Rheumatology | 2 | 1991 | 8 | 0.040 |
Why?
|
| Information Systems | 1 | 1998 | 23 | 0.040 |
Why?
|
| Patient Credit and Collection | 1 | 1998 | 1 | 0.040 |
Why?
|
| Risk Management | 1 | 1998 | 5 | 0.040 |
Why?
|
| Health Care Rationing | 1 | 1998 | 14 | 0.040 |
Why?
|
| Cost Control | 1 | 1998 | 25 | 0.040 |
Why?
|
| Algorithms | 2 | 2003 | 241 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 444 | 0.040 |
Why?
|
| Value of Life | 1 | 1998 | 7 | 0.040 |
Why?
|
| Hospital Costs | 1 | 1998 | 41 | 0.040 |
Why?
|
| Incidence | 3 | 2008 | 1314 | 0.040 |
Why?
|
| Attitude to Health | 1 | 2019 | 177 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1998 | 160 | 0.040 |
Why?
|
| Public Health | 1 | 1998 | 82 | 0.040 |
Why?
|
| Health Resources | 1 | 1997 | 38 | 0.040 |
Why?
|
| Age Distribution | 2 | 2009 | 261 | 0.040 |
Why?
|
| Penicillamine | 2 | 1995 | 2 | 0.040 |
Why?
|
| Social Support | 1 | 1998 | 214 | 0.040 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 211 | 0.040 |
Why?
|
| Cystoscopy | 2 | 2008 | 6 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 1037 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2019 | 256 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 1998 | 347 | 0.030 |
Why?
|
| Epidemiologic Methods | 2 | 2002 | 87 | 0.030 |
Why?
|
| Hydroxychloroquine | 1 | 1995 | 2 | 0.030 |
Why?
|
| New Hampshire | 1 | 1995 | 2 | 0.030 |
Why?
|
| Azathioprine | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hospitals, University | 1 | 1995 | 20 | 0.030 |
Why?
|
| Diagnosis-Related Groups | 1 | 1995 | 27 | 0.030 |
Why?
|
| Methotrexate | 1 | 1995 | 8 | 0.030 |
Why?
|
| Boston | 1 | 1995 | 37 | 0.030 |
Why?
|
| Telemedicine | 1 | 1998 | 184 | 0.030 |
Why?
|
| Models, Psychological | 1 | 1995 | 25 | 0.030 |
Why?
|
| Feces | 1 | 2015 | 88 | 0.030 |
Why?
|
| Health Behavior | 2 | 2012 | 374 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 47 | 0.030 |
Why?
|
| Peru | 1 | 2013 | 7 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 1995 | 598 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 25 | 0.030 |
Why?
|
| Confounding Factors (Epidemiology) | 1 | 2012 | 99 | 0.030 |
Why?
|
| Comparative Effectiveness Research | 1 | 2013 | 77 | 0.030 |
Why?
|
| Arm | 1 | 1992 | 5 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2012 | 38 | 0.030 |
Why?
|
| Relative Value Scales | 1 | 1991 | 3 | 0.030 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 95 | 0.030 |
Why?
|
| Fellowships and Scholarships | 1 | 1991 | 14 | 0.020 |
Why?
|
| Education, Medical | 1 | 1991 | 15 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 146 | 0.020 |
Why?
|
| Gastroenterology | 1 | 1991 | 19 | 0.020 |
Why?
|
| Pain | 1 | 1992 | 84 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 150 | 0.020 |
Why?
|
| Employment | 3 | 1981 | 48 | 0.020 |
Why?
|
| Nursing Care | 1 | 2010 | 5 | 0.020 |
Why?
|
| Nursing Staff, Hospital | 1 | 2010 | 12 | 0.020 |
Why?
|
| Sample Size | 1 | 2010 | 30 | 0.020 |
Why?
|
| Quality Control | 1 | 2010 | 48 | 0.020 |
Why?
|
| Allied Health Personnel | 1 | 2010 | 13 | 0.020 |
Why?
|
| Depression | 1 | 1995 | 518 | 0.020 |
Why?
|
| Geriatrics | 1 | 1989 | 8 | 0.020 |
Why?
|
| Diclofenac | 1 | 1989 | 1 | 0.020 |
Why?
|
| Hemochromatosis Protein | 1 | 2008 | 8 | 0.020 |
Why?
|
| Homozygote | 1 | 2008 | 14 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 1989 | 83 | 0.020 |
Why?
|
| Iron | 1 | 2008 | 17 | 0.020 |
Why?
|
| Uric Acid | 1 | 1988 | 11 | 0.020 |
Why?
|
| Radiography | 1 | 1988 | 41 | 0.020 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 2008 | 1 | 0.020 |
Why?
|
| Dysuria | 1 | 2008 | 1 | 0.020 |
Why?
|
| Prognosis | 1 | 1990 | 624 | 0.020 |
Why?
|
| Nocturia | 1 | 2008 | 5 | 0.020 |
Why?
|
| Registries | 1 | 2010 | 490 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2008 | 28 | 0.020 |
Why?
|
| Occupational Health Services | 1 | 2007 | 16 | 0.020 |
Why?
|
| Body Weight | 1 | 1989 | 223 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 61 | 0.020 |
Why?
|
| Pyuria | 1 | 2005 | 1 | 0.020 |
Why?
|
| Bacteriuria | 1 | 2005 | 3 | 0.020 |
Why?
|
| Joint Diseases | 1 | 1985 | 1 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 1985 | 1 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 27 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2007 | 271 | 0.020 |
Why?
|
| Resource Allocation | 1 | 2005 | 6 | 0.020 |
Why?
|
| Family Practice | 1 | 1985 | 53 | 0.020 |
Why?
|
| Family Relations | 1 | 2005 | 18 | 0.020 |
Why?
|
| Diet | 1 | 2007 | 371 | 0.020 |
Why?
|
| Comorbidity | 1 | 2007 | 619 | 0.020 |
Why?
|
| Genes, BRCA2 | 1 | 2005 | 9 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2005 | 10 | 0.020 |
Why?
|
| Health Care Sector | 1 | 2004 | 2 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 1985 | 180 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1983 | 43 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1983 | 167 | 0.010 |
Why?
|
| Models, Econometric | 1 | 2003 | 11 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2002 | 21 | 0.010 |
Why?
|
| Outpatients | 1 | 2003 | 111 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 157 | 0.010 |
Why?
|
| Cooperative Behavior | 1 | 2002 | 102 | 0.010 |
Why?
|
| Marriage | 1 | 1981 | 7 | 0.010 |
Why?
|
| Work | 1 | 1981 | 12 | 0.010 |
Why?
|
| Leisure Activities | 1 | 1981 | 33 | 0.010 |
Why?
|
| Motor Skills | 1 | 1999 | 2 | 0.010 |
Why?
|
| Hypertension | 1 | 1983 | 524 | 0.010 |
Why?
|
| Cost Allocation | 1 | 1997 | 2 | 0.010 |
Why?
|
| Joints | 1 | 1997 | 3 | 0.010 |
Why?
|
| Surgical Procedures, Operative | 1 | 1997 | 17 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1998 | 327 | 0.010 |
Why?
|
| Insurance, Health | 1 | 1978 | 217 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 2672 | 0.010 |
Why?
|
| Physical Examination | 1 | 1992 | 21 | 0.010 |
Why?
|
| Random Allocation | 1 | 1990 | 41 | 0.010 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1989 | 10 | 0.010 |
Why?
|
| Social Class | 1 | 1990 | 125 | 0.010 |
Why?
|
| Mental Health | 1 | 1989 | 168 | 0.000 |
Why?
|
| Orthopedics | 1 | 1985 | 5 | 0.000 |
Why?
|
| Polymyalgia Rheumatica | 1 | 1985 | 1 | 0.000 |
Why?
|
| Rheumatoid Factor | 1 | 1985 | 1 | 0.000 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1985 | 72 | 0.000 |
Why?
|
| Probability | 1 | 1980 | 86 | 0.000 |
Why?
|